[1]
I. Erturk, “Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin”, ijmsci, vol. 5, no. 11, pp. 4157-4161, Nov. 2018.